600 patients66,869 observations120 daysLIVE
← Patients

Patient P-01653

Synthetic patientNBL-101 · Day 117 · 35–44 · M · baseline S08Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Deteriorating
GI state
Deteriorating
Inflammatory state
Deteriorating
Nutritional resilience
Declining
Discontinuation risk
31%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events
solid = observed · dashed = predicted
  1. Day 0 NBL-101 started — Baseline state S08

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days
  • Inflammatory activity+12
  • GI instability+11
  • Toxicity+8
  • Nutritional resilience-5
  • Treatment adherence+3

What helped?

No interventions yet.

    LIFE OS recommendation
    No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

    Daily trackers

    Molecule settings

    The trackers this program marks as important, last 14 days vs the 14 before.

    GI burden
    Companion
    24.8/100
    stable · +0.3 vs previous 14 d
    Toxicity
    Blood
    22.6/100
    improving · -7.7 vs previous 14 d
    Sleep quality
    Wearable
    45.8/100
    stable · +0.2 vs previous 14 d
    Energy level
    Daily log
    5.8/10
    stable · -0.0 vs previous 14 d
    Stress level
    Daily log
    3.7/10
    improving · -0.3 vs previous 14 d
    Steps
    Wearable
    5,821
    stable · +98 vs previous 14 d
    Adherence
    Companion
    91.8 %
    stable · -3.7 vs previous 14 d
    This trajectory is decaying — what would help, what would not
    Steering view →

    Heading towards failing · 66 from the failing basin, 22 from restoration.

    Would help
    • No untried action with strong evidence. Compose one from primitives.
    Would not help
    • Keep spicy low
      GI +2.9 next day on high-intake days · n 19
    State influencers · digestive

    Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

    • Spicy / capsaicin
      +2.9detractor · 66%
    • Dietary fat load
      +2no signal · 32%
    • Histamine load
      +1no signal · 17%
    • Simple carbohydrates
      +0.8no signal · 15%
    • Insoluble fibre
      -0.8no signal · 18%
    • Alcohol
      +0.4no signal · 15%

    Biological layers

    Which pathways look influenced, and by which layer of this person's biology.

    Pathways under pressure
    • Drug metabolism and exposure ↑75
      • DNACYP2D6 poor metabolizer → higher exposure
      • DNADPYD *2A → slower clearance
    • Inflammatory signalling ↑25
      • DNAIL6 -174 variant raises baseline inflammatory tone
    • Autonomic recovery ↓25
      • WearableResting HR 73 bpm
    DNA
    Fictional pharmacogenomic panel
    • IL6 -174 G/C
      Higher inflammatory tone
    • DPYD *2A heterozygous
      Slower drug clearance
    • CYP2D6 Poor metabolizer
      Higher exposure at standard dose
    Microbiome
    Shannon diversity 3.1 · butyrate capacity 65/100
    • Akkermansia muciniphilaNormal
    • Faecalibacterium prausnitziiNormal
    • Bacteroides fragilisNormal
    • Bifidobacterium longumNormal
    • EnterobacteriaceaeHigh
    Wearable, last 14 days
    daily evolution fed into the runtime
    HRV
    47 ms
    Sleep
    7.1 h
    Steps
    6,283
    Resting HR
    73 bpm
    Daily log: GI score 25, nutritional resilience 64, adherence 92.

    What this patient sees in NostraAI

    The content that steers the trajectory: what to eat, what to do, what to take.

    Open companion preview
    What to eat
    • Keep meals regular; three to four moderate portions spaced through the day
    • Include a cooked vegetable portion with each main meal
    • Keep fibre steady; no new sources this week
    • Avoid known triggers for now: fried or oily food, dairy, alcohol
    What to do
    • Log the daily check-in; one line is enough
    • Keep the current walking rhythm
    • Keep the sleep window steady
    • Keep hydration steady: small amounts through the day rather than large volumes at once
    What to take
    • Take the scheduled dose as agreed with your care team
    • No additional supplements this week
    • Fictional demo item: continue vitamin D as before

    284 biologically similar trajectories

    Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

    Sort by similaritySort by interventionSort by outcomeSort by stateSort by response
    PatientSimilarityBaselineInterventionOutcomeResponse today
    P-0180447%S19AD-05improved61
    P-0154135%S09AD-05no change43
    P-0137734%S11AD-05no change42
    P-0148332%S14AD-05no change35
    P-0167931%S12AD-05no change39
    P-0168935%S13BR-03no change50
    P-0132933%S08BR-03improved79
    P-0135031%S19BR-03no change34
    P-0146830%S06BR-03no change41
    P-0167730%S05BR-03no change86
    P-0131329%S01BR-03improved32
    P-0149529%S07BR-03improved85